IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale

Joint venture Alpha Bio will use IFF’s proprietary Designed Enzymatic Biomaterials™ technology to provide high-performance, sustainable alternatives to fossil-based ingredients

NEW YORK--(BUSINESS WIRE)-- IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio’s production will use IFF’s Designed Enzymatic Biomaterial™ (DEB) platform technology, integrated at the IFF biorefinery in Kotka, Finland.

"Our partnership with Kemira has reached a significant milestone, enabling us to scale the production of groundbreaking biobased materials to meet the large and growing demand for high-performing and sustainable alternatives to fossil-derived polymers," said Erik Fyrwald, IFF CEO. "IFF’s DEB technology not only guarantees superior purity and consistency compared to traditional biopolymers but also enhances performance across various applications. This innovative approach allows us to combine biodegradability and material sustainability while maintaining cost efficiency and the high performance our customers expect."

IFF’s DEB platform leverages biotechnology by using plant-based sugars and enzymes under mild process conditions to create biobased materials, which can be tailored for specific product applications. This allows manufacturers to replace traditional fossil-based synthetic polymers with more sustainable alternatives. This highly efficient enzymatic polymerization process converts plant sugars to biopolymers, offering superior purity and consistency compared to conventional synthetic polymers. These tailored biopolymers enhance product performance across diverse applications.

“Since 2020, we’ve been collaborating with IFF using the DEB platform technology, which has allowed us to bring sustainable innovation to our key markets,” said Antti Salminen, CEO, Kemira Oyj. “The new joint venture will build on this initial success, enabling us to scale up production and provide new performance-competitive alternatives to fossil-based products in key markets, including paper and board packaging, paper coatings, and water treatment, while continuing to develop opportunities across other growth markets.”

Operating as an independent entity in Kotka, Finland, the joint venture will manufacture a specific line of products enabled by DEB technology for exclusive use by IFF and Kemira. The creation of Alpha Bio is expected to generate approximately 30 direct new jobs in the Kotka area with additional job creation during the project’s construction phase.

Visit www.iff.com for more information.

Cautionary Statement under the Private Securities Litigation Reform Act of 1995
This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “”plan”, “expect,” “anticipate,” “intend,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the timing or nature of the proposed expansion. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update the forward-looking statement to reflect subsequent events or circumstances.

Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity, and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

Welcome to Kemira
Kemira is a global leader in sustainable chemical solutions for water-intensive industries. We deliver tailored products and services to improve the product quality, processes, and resource efficiency of our diverse range of customers. Our focus is on water treatment, as well as on fiber and renewable solutions – enabling sustainability transformation for our customers. In 2024, Kemira reported annual revenue of EUR 2.9 billion with a global team of some 4,700 colleagues. Kemira is listed on the Nasdaq, Helsinki. More information: www.kemira.com

©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, ℠ or ^® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250326146003/en/

Media Relations:

Paulina Heinkel

332.877.5339

Media.request@iff.com

Investor Relations:

Michael Bender

212.708.7263

Investor.Relations@iff.com

Source: IFF

FAQ

When will IFF and Kemira's Alpha Bio joint venture begin production?

Alpha Bio's production facility is scheduled to begin operations in late 2027.

What is the production capacity of IFF's Alpha Bio facility in Finland?

The facility will convert up to 44,000 MT of plant sugars into bioproducts.

How much are IFF and Kemira investing in the Alpha Bio joint venture?

The joint venture involves an investment of approximately €130 million.

What technology will Alpha Bio use for biopolymer production?

Alpha Bio will use IFF's proprietary Designed Enzymatic Biomaterial™ (DEB) platform technology.

How many jobs will IFF's Alpha Bio joint venture create in Kotka, Finland?

The venture will create approximately 30 direct new jobs, plus additional positions during construction.